ZOLL R Series Monitor/Defibrillator
ZOLL MEDICAL CORPORATION · Decision date Oct 16, 2026
What did the FDA decide?
The FDA recorded decision OK30 on 2026-10-16 for PMA supplement P160022/S056, submitted by ZOLL Medical Corporation for the ZOLL R Series Monitor/Defibrillator. The supplement is filed as a 30-Day Notice with a recorded reason of process change affecting manufacturer, sterilizer, packager or supplier. The listed device category is automated external defibrillators (non-wearable), specialty Cardiovascular, product code MKJ.
The recorded statement describes an alternate critical component on the printed circuit board assembly. That scope concerns a component-level change within the existing PMA, not a new approval of the whole monitor/defibrillator system. The source record does not identify the specific component, the supplier, or the basis for the decision, and no supporting documents are listed, so the technical and clinical significance of the substitution cannot be assessed from this data alone.
FDA approval order statement
an alternate critical component on the printed circuit board assembly
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 16, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P160022/S056
- Regulatory pathway
- PMA supplement
- Applicant
- ZOLL MEDICAL CORPORATION
- Product code
- MKJ
- Decision code
- OK30
- Decision date
- Oct 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Automated external defibrillators (non-wearable).
- Applicant
- ZOLL MEDICAL CORPORATION
- Product code
- MKJ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P160022. Subsequent supplements may change the device or its indications.
FDA decision timeline
P160022 · Original PMA
X Series, R Series, AED Pro, AED 3 BLS Professional Defibrillators, Pro-Padz Radiotransparent Electrode, SurePower
P160022/S056 received
Application receipt date recorded by FDA.
P160022/S054 · Related supplement
X Series, R Series, AED Pro, AED 3 BLS Professional Defibrillators, Pro-Padz Radiotransparent Electrode, SurePower
P160022/S056 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P160022. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P160022
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ZOLL MEDICAL CORPORATION | PMA approval | Dec 27, 2017 | FDA | |
| ZOLL MEDICAL CORPORATION | PMA supplement | Oct 2, 2026 | FDA |
Explore the linked device profile
Other records with product code MKJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LIFEPAK 35 monitor/defibrillatorP160026/S076 | Physio-Control, Inc. | PMA supplement | Oct 29, 2026 | FDA |
AED 3 Defibrillator with Uni-PadzP160015/S029 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
| Physio-Control, Inc. | PMA supplement | Sep 24, 2026 | FDA | |
LIFEPAK 15 monitor/defibrillatorP160026/S073 | Physio-Control, Inc. | PMA supplement | Sep 10, 2026 | FDA |
LIFEPAK 35 monitor/defibrillatorP160026/S069 | Physio-Control, Inc. | PMA supplement | Sep 2, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
ZOLL MEDICAL CORPORATION
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 269 & 271 Mill Rd., Chelsmford, MA, 01824
Sources and methodology
- Original FDA record: P160022/S056
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



